Your session is about to expire
← Back to Search
Intraocular Lens
Intraocular Lenses for Cataracts
N/A
Waitlist Available
Led By Yaping Jin, MD, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial tests new artificial lenses for cataract surgery to see if they develop fewer tiny spots called glistenings. It targets cataract patients and compares two brands of lenses to find out which one performs better.
Eligible Conditions
- Cataract
- Transient Visual Acuity Loss
- Loss of Visual Contrast Sensitivity
- Functional Visual Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence and density (severity) of glistenings at 18-month follow-up visit
Secondary study objectives
Contrast sensitivity and glare disability in eyes with glistenings at 12-month follow-up visit
Contrast sensitivity in eyes with glistenings at 18-month follow-up visit
Contrast sensitivity in eyes with glistenings at 6-month follow-up visit
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Alcon lens groupExperimental Treatment1 Intervention
Alcon 1 piece SA60AT lens
Group II: AMO lens groupActive Control1 Intervention
AMO 1 piece Sensar AABOO lens
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
718 Previous Clinical Trials
1,042,470 Total Patients Enrolled
2 Trials studying Cataract
630 Patients Enrolled for Cataract
Kensington Eye InstituteOTHER
2 Previous Clinical Trials
445 Total Patients Enrolled
Yaping Jin, MD, PhDPrincipal InvestigatorUniversity of Toronto
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had eye surgery to improve your vision in the past.You have diabetes along with your other medical conditions.You have a condition that affects your cornea in both eyes.You have experienced complications following cataract surgery.You have an optic nerve disease along with the condition being treated in the clinical trial.You have uveitis (inflammation of the eye) along with your other medical conditions.You have an eye condition called macular disease.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Alcon lens group
- Group 2: AMO lens group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger